Ozempic may cause muscle loss, experts warn
New research warns that popular weight-loss drugs like Ozempic may lead to significant muscle loss, raising concerns among health experts. Discover the risks and alternatives.
Category : Search result: obesity treatment UK
NHS to trial weight loss jab Mounjaro in obesity pilot
The NHS is set to trial the weight loss injection Mounjaro, a drug hailed as a potential game-changer in obesity treatment, as part of a new pilot programme targeting adults struggling with weight issues.
NHS weight loss jabs face postcode lottery
New NHS weight loss injections, including Mounjaro, are being rolled out unevenly, creating a 'postcode lottery' for patients struggling with obesity.
Weight loss jabs may lead to significant regain after stopping
New research suggests that weight loss injections like Wegovy may lead to significant weight regain once discontinued, raising concerns about long-term effectiveness.
NHS to offer weight loss jabs in pharmacies
The NHS is expanding access to obesity treatments Mounjaro and Wegovy, making them available in local pharmacies following approval by NICE.
Weight returns after stopping skinny jabs
New research warns that patients who stop taking weight-loss injections like Wegovy may regain most of the lost weight, raising concerns about long-term effectiveness.
Weight loss wonder drugs transforming obesity treatment
Breakthrough diabetes medications like Mounjaro and Ozempic are showing remarkable weight loss results, transforming obesity treatment in the UK.
US to cover weight-loss drugs under Medicare/Medicaid
In a landmark decision, US healthcare programmes Medicare and Medicaid will now cover weight-loss medications, including Ozempic, marking a significant shift in obesity treatment policy.
Mounjaro & Ozempic: Weight Loss Breakthrough
New research reveals the surprising long-term benefits of weight loss injections like Mounjaro and Ozempic, offering hope for sustainable obesity management.
Weight-loss drug demand 'unsustainable', say pharmacists
UK pharmacists raise alarms over the skyrocketing demand for weight-loss medications, calling it unsustainable and urging for systemic changes.
Weight loss jabs now available in UK pharmacies
Slimming injections, once restricted to clinical settings, are now accessible in UK pharmacies, revolutionising obesity management with easier access and professional oversight.
Dad loses 7 stone with Mounjaro, now deals with loose skin
A father shares his incredible 7-stone weight loss journey using Mounjaro, but reveals the unexpected challenge of dealing with excess skin.
Weight loss injections may relieve asthma symptoms
New research suggests that GLP-1 receptor agonists, commonly used for weight loss, may also improve asthma symptoms in obese individuals. Discover the potential dual benefits of these medications.
Weight loss jabs may ease asthma symptoms
New research suggests that weight loss injections like Ozempic may significantly reduce asthma symptoms in obese individuals, offering a dual health benefit.
Weight Loss Wonder Drugs: Mounjaro & Ozempic Boom
Discover how diabetes medications like Mounjaro and Ozempic are being repurposed as revolutionary weight loss treatments, sparking global demand and ethical debates.
Weight loss jabs may transform obesity treatment
New research indicates that weight loss injections such as Ozempic and Wegovy may revolutionise obesity management, offering hope for millions struggling with weight-related health issues.
DNA test predicts childhood obesity risk
A groundbreaking DNA test may soon help identify children at risk of obesity early, offering parents and doctors a chance to intervene before health issues arise.
Mounjaro users reveal hardest side effects
Patients using Mounjaro for weight loss reveal the unexpected side effects and struggles they face, from nausea to emotional hurdles.
AI tool predicts childhood obesity with 80% accuracy
A groundbreaking AI-powered tool can now predict childhood obesity with high accuracy, offering early intervention opportunities to combat the growing health crisis.
3 stone weight loss with Mounjaro: The hidden downsides
One woman's incredible 3-stone weight loss transformation using Mounjaro reveals both the triumphs and the unexpected challenges of this groundbreaking treatment.
Woman’s taste buds ruined by weight-loss jab Mounjaro
A woman shares her shocking experience with the weight-loss injection Mounjaro, revealing how it altered her taste buds, leaving her struggling to eat.
Weight-loss jabs linked to 5 deaths in Scotland
Five deaths in Scotland have been linked to popular weight-loss injections, prompting calls for an urgent safety review. Experts warn of potential risks as demand for these treatments soars.
Weight loss jabs transforming Gen X health
New research reveals that weight loss injections like Mounjaro and Wegovy are proving highly effective for Generation X, offering hope in the battle against obesity.
Man loses 14 stone with Mounjaro’s surprising side effect
A 31-year-old man lost an incredible 14 stone with the help of Mounjaro, revealing an unexpected side effect that transformed his habits and health.
Weight Loss Jabs Could Be Banned in UK
Experts warn that two widely used weight loss injections may face restrictions in the UK due to safety concerns. Here’s the latest on the potential ban and alternatives.
Weight Loss Jabs Offer Major Health Benefits Beyond Shedding Pounds
New research reveals that weight loss injections like Mounjaro and Wegovy offer significant health benefits, including reduced risk of heart disease and diabetes, beyond just aiding weight reduction.
Weight loss jabs may slash heart attack risk
Breakthrough research suggests that popular weight loss injections like Wegovy and Ozempic may significantly reduce the risk of cardiovascular events, offering hope for millions.
Okra: The Natural Ozempic Alternative?
Scientists uncover the potential of okra as a natural remedy for obesity, diabetes, and heart disease—could this humble vegetable replace weight-loss drugs like Ozempic?
Weight-loss drugs linked to serious digestive issues
New research reveals that popular weight-loss medications Wegovy and Mounjaro may increase the risk of severe stomach and intestinal problems, including paralysis and pancreatitis.
NHS to offer Wegovy and Mounjaro weight-loss drugs
The NHS is set to provide Wegovy and Mounjaro, groundbreaking weight-loss medications, following new evidence of their health benefits beyond obesity treatment.
Page 4 of 4